Qiagen seeks judgment in COVID-19 wastewater testing suit
07-04-2022
Jury rules Qiagen infringed two gene patents
31-08-2021
Oxford Immunotec settles with Qiagen, signs $27.5m licence
18-12-2017
T. Schneider / Shutterstock.com
Qiagen will pay Becton, Dickinson (BD) $53 million to settle an ongoing patent infringement lawsuit over polymerase chain reaction (PCR) diagnostics patents.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Qiagen, PCR, Becton Dickison, NeuMoDx, US District Court for the District of Delaware
